Biomarker Research (Dec 2021)

A comprehensive comparison between camelid nanobodies and single chain variable fragments

  • Yasaman Asaadi,
  • Fatemeh Fazlollahi Jouneghani,
  • Sara Janani,
  • Fatemeh Rahbarizadeh

DOI
https://doi.org/10.1186/s40364-021-00332-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 20

Abstract

Read online

Abstract By the emergence of recombinant DNA technology, many antibody fragments have been developed devoid of undesired properties of natural immunoglobulins. Among them, camelid heavy-chain variable domains (VHHs) and single-chain variable fragments (scFvs) are the most favored ones. While scFv is used widely in various applications, camelid antibodies (VHHs) can serve as an alternative because of their superior chemical and physical properties such as higher solubility, stability, smaller size, and lower production cost. Here, these two counterparts are compared in structure and properties to identify which one is more suitable for each of their various therapeutic, diagnosis, and research applications.

Keywords